nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—ALB—Captopril—systemic scleroderma	0.205	0.366	CbGbCtD
Bismuth Subsalicylate—ALB—Mycophenolate mofetil—systemic scleroderma	0.161	0.288	CbGbCtD
Bismuth Subsalicylate—ALB—Prednisone—systemic scleroderma	0.129	0.23	CbGbCtD
Bismuth Subsalicylate—ALB—Methotrexate—systemic scleroderma	0.0647	0.116	CbGbCtD
Bismuth Subsalicylate—TF—blood vessel—systemic scleroderma	0.0149	0.145	CbGeAlD
Bismuth Subsalicylate—PTGS2—skeletal joint—systemic scleroderma	0.0129	0.126	CbGeAlD
Bismuth Subsalicylate—TF—connective tissue—systemic scleroderma	0.00763	0.0742	CbGeAlD
Bismuth Subsalicylate—TF—skin of body—systemic scleroderma	0.00689	0.067	CbGeAlD
Bismuth Subsalicylate—PTGS1—artery—systemic scleroderma	0.00567	0.0551	CbGeAlD
Bismuth Subsalicylate—TF—digestive system—systemic scleroderma	0.00551	0.0536	CbGeAlD
Bismuth Subsalicylate—PTGS2—artery—systemic scleroderma	0.00542	0.0526	CbGeAlD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.005	0.624	CbGdCrCtD
Bismuth Subsalicylate—PTGS1—endothelium—systemic scleroderma	0.00479	0.0465	CbGeAlD
Bismuth Subsalicylate—TF—lung—systemic scleroderma	0.0046	0.0447	CbGeAlD
Bismuth Subsalicylate—PTGS2—endothelium—systemic scleroderma	0.00458	0.0445	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood vessel—systemic scleroderma	0.00441	0.0429	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood vessel—systemic scleroderma	0.00422	0.041	CbGeAlD
Bismuth Subsalicylate—TF—Differentiation Pathway—CSF1—systemic scleroderma	0.00373	0.105	CbGpPWpGaD
Bismuth Subsalicylate—Fluid overload—Mycophenolate mofetil—systemic scleroderma	0.0032	0.0109	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00302	0.376	CbGdCrCtD
Bismuth Subsalicylate—Lung disorder—Mycophenolate mofetil—systemic scleroderma	0.00281	0.00956	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—SELP—systemic scleroderma	0.00257	0.0725	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00254	0.00866	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.00245	0.069	CbGpPWpGaD
Bismuth Subsalicylate—Oesophagitis—Leflunomide—systemic scleroderma	0.00241	0.00822	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Leflunomide—systemic scleroderma	0.00239	0.00813	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Pentoxifylline—systemic scleroderma	0.00237	0.00805	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Captopril—systemic scleroderma	0.00234	0.00795	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Mycophenolic acid—systemic scleroderma	0.0023	0.00784	CcSEcCtD
Bismuth Subsalicylate—Asthma—Mometasone—systemic scleroderma	0.00229	0.00779	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Mycophenolic acid—systemic scleroderma	0.00228	0.00775	CcSEcCtD
Bismuth Subsalicylate—PTGS1—connective tissue—systemic scleroderma	0.00226	0.022	CbGeAlD
Bismuth Subsalicylate—Epistaxis—Pentoxifylline—systemic scleroderma	0.00223	0.00759	CcSEcCtD
Bismuth Subsalicylate—PTGS2—connective tissue—systemic scleroderma	0.00216	0.021	CbGeAlD
Bismuth Subsalicylate—Hepatitis—Pentoxifylline—systemic scleroderma	0.00212	0.00723	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Mycophenolic acid—systemic scleroderma	0.00212	0.00723	CcSEcCtD
Bismuth Subsalicylate—PTGS1—smooth muscle tissue—systemic scleroderma	0.00207	0.0201	CbGeAlD
Bismuth Subsalicylate—Deafness—Mycophenolic acid—systemic scleroderma	0.00204	0.00696	CcSEcCtD
Bismuth Subsalicylate—PTGS1—skin of body—systemic scleroderma	0.00204	0.0199	CbGeAlD
Bismuth Subsalicylate—Lightheadedness—Lisinopril—systemic scleroderma	0.00203	0.00691	CcSEcCtD
Bismuth Subsalicylate—PTGS2—smooth muscle tissue—systemic scleroderma	0.00198	0.0192	CbGeAlD
Bismuth Subsalicylate—PTGS2—skin of body—systemic scleroderma	0.00195	0.019	CbGeAlD
Bismuth Subsalicylate—Epistaxis—Mometasone—systemic scleroderma	0.00193	0.00655	CcSEcCtD
Bismuth Subsalicylate—Erythema—Pentoxifylline—systemic scleroderma	0.00185	0.00629	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.00184	0.00625	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00618	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00181	0.00616	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.0018	0.00612	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00168	0.00573	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.00168	0.0057	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00167	0.00569	CcSEcCtD
Bismuth Subsalicylate—Asthma—Leflunomide—systemic scleroderma	0.00166	0.00564	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Lisinopril—systemic scleroderma	0.00165	0.00563	CcSEcCtD
Bismuth Subsalicylate—PTGS1—digestive system—systemic scleroderma	0.00163	0.0159	CbGeAlD
Bismuth Subsalicylate—Burning sensation—Methotrexate—systemic scleroderma	0.00162	0.00552	CcSEcCtD
Bismuth Subsalicylate—Deafness—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00549	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Captopril—systemic scleroderma	0.00161	0.00548	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Captopril—systemic scleroderma	0.0016	0.00545	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Methotrexate—systemic scleroderma	0.00159	0.00542	CcSEcCtD
Bismuth Subsalicylate—Asthma—Mycophenolic acid—systemic scleroderma	0.00158	0.00538	CcSEcCtD
Bismuth Subsalicylate—PTGS2—digestive system—systemic scleroderma	0.00156	0.0152	CbGeAlD
Bismuth Subsalicylate—PTGS1—tendon—systemic scleroderma	0.00156	0.0151	CbGeAlD
Bismuth Subsalicylate—Erythema multiforme—Captopril—systemic scleroderma	0.00152	0.00518	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Pentoxifylline—systemic scleroderma	0.00152	0.00518	CcSEcCtD
Bismuth Subsalicylate—Oedema—Pentoxifylline—systemic scleroderma	0.00151	0.00514	CcSEcCtD
Bismuth Subsalicylate—Infection—Pentoxifylline—systemic scleroderma	0.0015	0.0051	CcSEcCtD
Bismuth Subsalicylate—PTGS2—tendon—systemic scleroderma	0.00149	0.0144	CbGeAlD
Bismuth Subsalicylate—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00493	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Mycophenolic acid—systemic scleroderma	0.00144	0.0049	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Pentoxifylline—systemic scleroderma	0.00144	0.0049	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.00143	0.0403	CbGpPWpGaD
Bismuth Subsalicylate—Asthma—Lisinopril—systemic scleroderma	0.00142	0.00485	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Leflunomide—systemic scleroderma	0.00139	0.00474	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Captopril—systemic scleroderma	0.00137	0.00467	CcSEcCtD
Bismuth Subsalicylate—PTGS1—lung—systemic scleroderma	0.00137	0.0133	CbGeAlD
Bismuth Subsalicylate—Somnolence—Pentoxifylline—systemic scleroderma	0.00134	0.00457	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00133	0.00453	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00133	0.00452	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Azathioprine—systemic scleroderma	0.00133	0.00452	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Leflunomide—systemic scleroderma	0.00133	0.00451	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00131	0.00446	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lung—systemic scleroderma	0.0013	0.0127	CbGeAlD
Bismuth Subsalicylate—Weight increased—Lisinopril—systemic scleroderma	0.0013	0.00441	CcSEcCtD
Bismuth Subsalicylate—Infection—Mometasone—systemic scleroderma	0.00129	0.0044	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Methotrexate—systemic scleroderma	0.00129	0.00439	CcSEcCtD
Bismuth Subsalicylate—Constipation—Pentoxifylline—systemic scleroderma	0.00129	0.00439	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Prednisone—systemic scleroderma	0.00129	0.00438	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00127	0.00431	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Mycophenolic acid—systemic scleroderma	0.00126	0.00429	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Leflunomide—systemic scleroderma	0.00125	0.00427	CcSEcCtD
Bismuth Subsalicylate—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00425	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00124	0.00423	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mometasone—systemic scleroderma	0.00124	0.00422	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Prednisone—systemic scleroderma	0.00123	0.00419	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisone—systemic scleroderma	0.00122	0.00415	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Pentoxifylline—systemic scleroderma	0.0012	0.00408	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Lisinopril—systemic scleroderma	0.0012	0.00408	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00119	0.00406	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00118	0.00402	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Captopril—systemic scleroderma	0.00115	0.00392	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mometasone—systemic scleroderma	0.00115	0.0039	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Lisinopril—systemic scleroderma	0.00114	0.00388	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.00114	0.0321	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00386	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Lisinopril—systemic scleroderma	0.00113	0.00386	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.00113	0.032	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Mometasone—systemic scleroderma	0.00113	0.00385	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Leflunomide—systemic scleroderma	0.00113	0.00385	CcSEcCtD
Bismuth Subsalicylate—Pain—Mometasone—systemic scleroderma	0.00111	0.00379	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Captopril—systemic scleroderma	0.00109	0.00371	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Lisinopril—systemic scleroderma	0.00108	0.00367	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—systemic scleroderma	0.00108	0.00366	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Pentoxifylline—systemic scleroderma	0.00107	0.00363	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00106	0.03	CbGpPWpGaD
Bismuth Subsalicylate—Tinnitus—Lisinopril—systemic scleroderma	0.00106	0.00362	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00357	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00103	0.00351	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mometasone—systemic scleroderma	0.00103	0.0035	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—systemic scleroderma	0.00102	0.00347	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Captopril—systemic scleroderma	0.00102	0.00346	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Captopril—systemic scleroderma	0.00101	0.00343	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000999	0.0034	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Prednisone—systemic scleroderma	0.000998	0.0034	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Pentoxifylline—systemic scleroderma	0.000998	0.0034	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Captopril—systemic scleroderma	0.000994	0.00338	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000994	0.00338	CcSEcCtD
Bismuth Subsalicylate—Erythema—Lisinopril—systemic scleroderma	0.000992	0.00338	CcSEcCtD
Bismuth Subsalicylate—Infection—Azathioprine—systemic scleroderma	0.000991	0.00337	CcSEcCtD
Bismuth Subsalicylate—Constipation—Captopril—systemic scleroderma	0.000978	0.00333	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.000974	0.0275	CbGpPWpGaD
Bismuth Subsalicylate—Dysgeusia—Lisinopril—systemic scleroderma	0.000972	0.00331	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000969	0.0273	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Pentoxifylline—systemic scleroderma	0.000959	0.00327	CcSEcCtD
Bismuth Subsalicylate—Rash—Pentoxifylline—systemic scleroderma	0.000951	0.00324	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Pentoxifylline—systemic scleroderma	0.00095	0.00323	CcSEcCtD
Bismuth Subsalicylate—Headache—Pentoxifylline—systemic scleroderma	0.000945	0.00322	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Captopril—systemic scleroderma	0.000942	0.00321	CcSEcCtD
Bismuth Subsalicylate—Infection—Leflunomide—systemic scleroderma	0.000936	0.00319	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00317	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Mometasone—systemic scleroderma	0.000921	0.00313	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Mycophenolic acid—systemic scleroderma	0.000906	0.00309	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Captopril—systemic scleroderma	0.000904	0.00308	CcSEcCtD
Bismuth Subsalicylate—ALB—Lipoprotein metabolism—HSPG2—systemic scleroderma	0.000903	0.0255	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Mycophenolic acid—systemic scleroderma	0.000899	0.00306	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Leflunomide—systemic scleroderma	0.000898	0.00306	CcSEcCtD
Bismuth Subsalicylate—Nausea—Pentoxifylline—systemic scleroderma	0.000896	0.00305	CcSEcCtD
Bismuth Subsalicylate—Infection—Mycophenolic acid—systemic scleroderma	0.000893	0.00304	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mometasone—systemic scleroderma	0.000891	0.00303	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000857	0.00292	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000851	0.0029	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.00084	0.0237	CbGpPWpGaD
Bismuth Subsalicylate—Lethargy—Methotrexate—systemic scleroderma	0.000834	0.00284	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Leflunomide—systemic scleroderma	0.000829	0.00282	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mometasone—systemic scleroderma	0.000828	0.00282	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Azathioprine—systemic scleroderma	0.000822	0.0028	CcSEcCtD
Bismuth Subsalicylate—Rash—Mometasone—systemic scleroderma	0.000821	0.00279	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mometasone—systemic scleroderma	0.00082	0.00279	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Leflunomide—systemic scleroderma	0.000819	0.00279	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Lisinopril—systemic scleroderma	0.000816	0.00278	CcSEcCtD
Bismuth Subsalicylate—Headache—Mometasone—systemic scleroderma	0.000816	0.00278	CcSEcCtD
Bismuth Subsalicylate—Oedema—Lisinopril—systemic scleroderma	0.00081	0.00276	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Captopril—systemic scleroderma	0.000809	0.00275	CcSEcCtD
Bismuth Subsalicylate—Pain—Leflunomide—systemic scleroderma	0.000806	0.00274	CcSEcCtD
Bismuth Subsalicylate—Constipation—Leflunomide—systemic scleroderma	0.000806	0.00274	CcSEcCtD
Bismuth Subsalicylate—Infection—Lisinopril—systemic scleroderma	0.000804	0.00274	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Mycophenolic acid—systemic scleroderma	0.000799	0.00272	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000791	0.00269	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Azathioprine—systemic scleroderma	0.000789	0.00268	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Captopril—systemic scleroderma	0.000782	0.00266	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000781	0.00266	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000777	0.00264	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mometasone—systemic scleroderma	0.000773	0.00263	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Lisinopril—systemic scleroderma	0.000772	0.00263	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisone—systemic scleroderma	0.00077	0.00262	CcSEcCtD
Bismuth Subsalicylate—Pain—Mycophenolic acid—systemic scleroderma	0.000769	0.00262	CcSEcCtD
Bismuth Subsalicylate—Constipation—Mycophenolic acid—systemic scleroderma	0.000769	0.00262	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000761	0.0215	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Captopril—systemic scleroderma	0.000756	0.00257	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Leflunomide—systemic scleroderma	0.000749	0.00255	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Leflunomide—systemic scleroderma	0.000745	0.00254	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—systemic scleroderma	0.000742	0.0209	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000741	0.00252	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Captopril—systemic scleroderma	0.000727	0.00247	CcSEcCtD
Bismuth Subsalicylate—Rash—Captopril—systemic scleroderma	0.000721	0.00245	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Captopril—systemic scleroderma	0.00072	0.00245	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Lisinopril—systemic scleroderma	0.00072	0.00245	CcSEcCtD
Bismuth Subsalicylate—Headache—Captopril—systemic scleroderma	0.000716	0.00244	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00243	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000713	0.0201	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Lisinopril—systemic scleroderma	0.000713	0.00243	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000711	0.00242	CcSEcCtD
Bismuth Subsalicylate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000709	0.00241	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—systemic scleroderma	0.000707	0.00241	CcSEcCtD
Bismuth Subsalicylate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000705	0.0024	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Lisinopril—systemic scleroderma	0.000704	0.0024	CcSEcCtD
Bismuth Subsalicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—systemic scleroderma	0.000703	0.0198	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Lisinopril—systemic scleroderma	0.000692	0.00236	CcSEcCtD
Bismuth Subsalicylate—Pain—Lisinopril—systemic scleroderma	0.000692	0.00236	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Azathioprine—systemic scleroderma	0.000683	0.00232	CcSEcCtD
Bismuth Subsalicylate—Nausea—Captopril—systemic scleroderma	0.000679	0.00231	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000678	0.00231	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000676	0.0023	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Prednisone—systemic scleroderma	0.000673	0.00229	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000667	0.00227	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Leflunomide—systemic scleroderma	0.000667	0.00227	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Azathioprine—systemic scleroderma	0.00066	0.00225	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Leflunomide—systemic scleroderma	0.000645	0.00219	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Lisinopril—systemic scleroderma	0.000643	0.00219	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Lisinopril—systemic scleroderma	0.00064	0.00218	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000636	0.00216	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Azathioprine—systemic scleroderma	0.000634	0.00216	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000631	0.00215	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—systemic scleroderma	0.00063	0.00214	CcSEcCtD
Bismuth Subsalicylate—Rash—Azathioprine—systemic scleroderma	0.000629	0.00214	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Azathioprine—systemic scleroderma	0.000629	0.00214	CcSEcCtD
Bismuth Subsalicylate—Headache—Azathioprine—systemic scleroderma	0.000625	0.00213	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000624	0.00213	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Leflunomide—systemic scleroderma	0.000623	0.00212	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000617	0.0021	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000615	0.00209	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic scleroderma	0.000614	0.0173	CbGpPWpGaD
Bismuth Subsalicylate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00207	CcSEcCtD
Bismuth Subsalicylate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00207	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—systemic scleroderma	0.000604	0.017	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Lipid and lipoprotein metabolism—HSPG2—systemic scleroderma	0.0006	0.0169	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Leflunomide—systemic scleroderma	0.000599	0.00204	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000594	0.00202	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—systemic scleroderma	0.000594	0.00202	CcSEcCtD
Bismuth Subsalicylate—Rash—Leflunomide—systemic scleroderma	0.000594	0.00202	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Leflunomide—systemic scleroderma	0.000594	0.00202	CcSEcCtD
Bismuth Subsalicylate—Nausea—Azathioprine—systemic scleroderma	0.000593	0.00202	CcSEcCtD
Bismuth Subsalicylate—Headache—Leflunomide—systemic scleroderma	0.00059	0.00201	CcSEcCtD
Bismuth Subsalicylate—Erythema—Prednisone—systemic scleroderma	0.000589	0.00201	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SELP—systemic scleroderma	0.000587	0.0166	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00199	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Lisinopril—systemic scleroderma	0.000573	0.00195	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000572	0.00195	CcSEcCtD
Bismuth Subsalicylate—Rash—Mycophenolic acid—systemic scleroderma	0.000567	0.00193	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000566	0.00193	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—systemic scleroderma	0.000566	0.00193	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000564	0.00192	CcSEcCtD
Bismuth Subsalicylate—Headache—Mycophenolic acid—systemic scleroderma	0.000563	0.00192	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000561	0.00191	CcSEcCtD
Bismuth Subsalicylate—Nausea—Leflunomide—systemic scleroderma	0.00056	0.00191	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Lisinopril—systemic scleroderma	0.000554	0.00189	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—RHOB—systemic scleroderma	0.000548	0.0155	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Lisinopril—systemic scleroderma	0.000535	0.00182	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000535	0.00182	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mycophenolic acid—systemic scleroderma	0.000534	0.00182	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—systemic scleroderma	0.000527	0.0018	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—CSF1—systemic scleroderma	0.000527	0.0149	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Lisinopril—systemic scleroderma	0.000515	0.00175	CcSEcCtD
Bismuth Subsalicylate—Rash—Lisinopril—systemic scleroderma	0.000511	0.00174	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.00051	0.0144	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Lisinopril—systemic scleroderma	0.00051	0.00174	CcSEcCtD
Bismuth Subsalicylate—Headache—Lisinopril—systemic scleroderma	0.000507	0.00173	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00171	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—CSK—systemic scleroderma	0.000499	0.0141	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—systemic scleroderma	0.000493	0.0139	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Methotrexate—systemic scleroderma	0.000492	0.00168	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—COL1A2—systemic scleroderma	0.00049	0.0138	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00165	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—systemic scleroderma	0.000482	0.00164	CcSEcCtD
Bismuth Subsalicylate—Nausea—Lisinopril—systemic scleroderma	0.000481	0.00164	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisone—systemic scleroderma	0.000481	0.00164	CcSEcCtD
Bismuth Subsalicylate—Infection—Prednisone—systemic scleroderma	0.000478	0.00163	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000475	0.0134	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.00047	0.0133	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ITGAM—systemic scleroderma	0.000469	0.0132	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000469	0.0016	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—SELP—systemic scleroderma	0.000468	0.0132	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Prednisone—systemic scleroderma	0.000458	0.00156	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000451	0.00154	CcSEcCtD
Bismuth Subsalicylate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00152	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000447	0.00152	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—SELP—systemic scleroderma	0.000446	0.0126	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000444	0.00151	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—SELP—systemic scleroderma	0.000424	0.012	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Prednisone—systemic scleroderma	0.000423	0.00144	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00143	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Prednisone—systemic scleroderma	0.000418	0.00142	CcSEcCtD
Bismuth Subsalicylate—Constipation—Prednisone—systemic scleroderma	0.000411	0.0014	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—systemic scleroderma	0.000405	0.00138	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—systemic scleroderma	0.000399	0.00136	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000397	0.0112	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisone—systemic scleroderma	0.000396	0.00135	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000396	0.0112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00039	0.011	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Methotrexate—systemic scleroderma	0.000383	0.0013	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisone—systemic scleroderma	0.000382	0.0013	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Prednisone—systemic scleroderma	0.00038	0.00129	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000372	0.0105	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Methotrexate—systemic scleroderma	0.000357	0.00122	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—systemic scleroderma	0.000354	0.0012	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—systemic scleroderma	0.000349	0.00119	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—systemic scleroderma	0.000344	0.00117	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Prednisone—systemic scleroderma	0.00034	0.00116	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000331	0.00113	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Prednisone—systemic scleroderma	0.000329	0.00112	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—systemic scleroderma	0.000319	0.00109	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Prednisone—systemic scleroderma	0.000318	0.00108	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—systemic scleroderma	0.000318	0.00108	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Prednisone—systemic scleroderma	0.000306	0.00104	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisone—systemic scleroderma	0.000303	0.00103	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisone—systemic scleroderma	0.000303	0.00103	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisone—systemic scleroderma	0.000301	0.00103	CcSEcCtD
Bismuth Subsalicylate—Nausea—Prednisone—systemic scleroderma	0.000286	0.000972	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—systemic scleroderma	0.000284	0.000968	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—systemic scleroderma	0.000275	0.000936	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—systemic scleroderma	0.000266	0.000905	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—systemic scleroderma	0.000256	0.00087	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—systemic scleroderma	0.000253	0.000863	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—systemic scleroderma	0.000253	0.000862	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—systemic scleroderma	0.000252	0.000857	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—systemic scleroderma	0.000239	0.000813	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—MMP1—systemic scleroderma	0.000235	0.00664	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.00022	0.00621	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.000219	0.00617	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000219	0.00617	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.000208	0.00586	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1A—systemic scleroderma	0.000201	0.00567	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.000194	0.00547	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CCL2—systemic scleroderma	0.000178	0.00502	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.000176	0.00498	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000175	0.00493	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS3—systemic scleroderma	0.000171	0.00481	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000167	0.00471	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000166	0.00468	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000141	0.00399	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCL2—systemic scleroderma	0.000138	0.0039	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—systemic scleroderma	0.000135	0.00381	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000134	0.00377	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000132	0.00374	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—systemic scleroderma	0.000113	0.00318	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000107	0.00302	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SELP—systemic scleroderma	0.000107	0.00302	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000106	0.00299	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—systemic scleroderma	0.000105	0.00296	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000101	0.00286	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RHOB—systemic scleroderma	9.99e-05	0.00282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—systemic scleroderma	9.88e-05	0.00279	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CSK—systemic scleroderma	9.1e-05	0.00257	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—systemic scleroderma	8.99e-05	0.00254	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.57e-05	0.00242	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	8.56e-05	0.00242	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGAM—systemic scleroderma	8.55e-05	0.00241	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—systemic scleroderma	8.14e-05	0.0023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	8.03e-05	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SMAD7—systemic scleroderma	7.73e-05	0.00218	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFBI—systemic scleroderma	7.07e-05	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.5e-05	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSPG2—systemic scleroderma	5.95e-05	0.00168	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HSPG2—systemic scleroderma	5.64e-05	0.00159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	5.54e-05	0.00156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CSK—systemic scleroderma	5.44e-05	0.00154	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD247—systemic scleroderma	5.12e-05	0.00144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSPG2—systemic scleroderma	4.72e-05	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CTGF—systemic scleroderma	4.51e-05	0.00127	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MMP1—systemic scleroderma	4.29e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	3.99e-05	0.00112	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSPG2—systemic scleroderma	3.82e-05	0.00108	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CTGF—systemic scleroderma	3.58e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—systemic scleroderma	3.11e-05	0.000877	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CTGF—systemic scleroderma	2.89e-05	0.000817	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—systemic scleroderma	2.05e-05	0.00058	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—systemic scleroderma	1.96e-05	0.000553	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—systemic scleroderma	1.86e-05	0.000525	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—systemic scleroderma	1.56e-05	0.000439	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—systemic scleroderma	1.26e-05	0.000355	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—systemic scleroderma	1.23e-05	0.000347	CbGpPWpGaD
